The Hindu Business Line : Strides picks up majority stake in LatAm venture

STRIDES Arcolab on Monday said it had acquired a controlling stake in its Latin American venture, becoming the largest Indian pharma company to operate in the lucrative $22-billion LatAm market.

Strides has acquired an additional stake of 12.5 per cent at a cost of $6 million in its joint venture, Strides Latina, from its Brazilian partner, Elcemar Almeida & Associates. It now owns 52.5 per cent or controlling stake in the joint venture.

The Bangalore company's sales from its LatAm operations (from Brazil and Mexico) stand at Rs 195 crore (about $45 million) for the 12-month period ended September 2004.

Brazilian entity Cellofarma is fully owned by Strides Latina, which has a 74-per cent stake in Mexican company Solara, SA de C.V.

"With the manufacturing facilities in Brazil and Mexico, Strides is now a strong regional player in this market, having strong management, sales and manufacturing capabilities with technologies and products from India. The consolidation exercise in Latin America will further help us in becoming a significant player in this market," said the Chairman of Strides Arcolab, Mr Arun Kumar.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Unichem plants get approval from Brazil

Zydus files IND application

Rayalaseema Alkalies record date

Bombay HC rejects Western Coalfields plea; Durgapur mines shut down

Internal auditors urged to use IT services

Vijay Textiles buys 4.17 pc stake in Suryajyoti Spinning

Beeyu Overseas plans to buy tea factory in Lanka

Strides picks up majority stake in LatAm venture

Amtek board okays Sigma buy

Wipro sets up plant in HP for Santoor soap

Bajaj Hind to set up distillery

Matrix Labs inks alliance with MCHEM of China

MRPL inks crude supply deals with Saudi, Iranian cos

Ashok Leyland doubles exports

Tata Motors vehicle sales up by 22.5 pc